This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Mergers & Acquisitions

Jul. 8, 2003

Pharmaceutical Firms Will Join Forces

In another massive biotechnology deal, Biogen Inc. and Idec Pharmaceuticals Corp. have agreed to merge in a multibillion-dollar stock swap.

By Toni Vranjes
        In another massive biotechnology deal, Biogen Inc. and Idec Pharmaceuticals Corp. have agreed to merge in a multibillion-dollar stock swap.
        The deal was valued at $6.4 billion when it was announced in June, making it the largest biotech deal since the $17.7 billion merger of Amgen Inc. and Immunex Corp. that closed ...

To continue reading, please subscribe.

Already a subscriber?

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)